H.R. 1730/S. 670- Speeding Therapy Access Today Act; H.R. 483/S. 350 - Newborn Screening Saves Lives Act; H.R. 6000 Cures 2.0 Act; H.R. 6584 Diverse and Equitable Participation in Clinical Trials Act; S. 2706/H.R. 5030 Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act; H.R. 6963 - Accelerated Approval Integrity Act; H.R. 6996 - Accelerating Access for Patients Act - General issues related to rare disease and orphan drugs; Reauthorization of the FDA User Fee Act; FDA modernization policy issues; Reauthorization of newborn screening programs; Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients; General issues related to health equity in rare disease and clinical trials; General issues related to diagnostics for patients with rare diseases Cancer screening, diagnosis & treatment Prescription drug electronic labeling H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 - Lower Costs, More Cures Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 - Build Back Better Act H.R. 3085/S. 1548 -ENACT Act of 2021 H.R. 5585 - Advanced Research Project Agency-Health Act H.R. 2883, Stop Stalling Access to Affordable Medications Issues related to COVID-19 vaccines and therapies; Items related to the Administrations Cancer Moonshot S. 3799, the PREVENT Pandemics Act S. 3509 Creating Efficiency in Foreign Facility Inspections Act Prescription Drug User Fee Act (PDUFA) H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 - Lower Costs, More Cures Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 - Build Back Better Act - General issues related to patient access to rare disease therapies, Part B and Part D drugs; Issues related to home infusion for Part B patients; Center for Medicare and Medicaid Innovation (CMMI) policy issues; Value-based payment arrangements; Efforts to improve coding, coverage, and access for rare disease therapies; Issues related to low volume Diagnosis Related Groups (DRGs) and rare therapies; General issues related to diagnostic reimbursement S. 1873/H.R. 1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 Issues related to the 340B drug discount program. Discussions related to an appropriations hold on funding for a 2014 FDA rule that would move package inserts (PI) from paper to digital form-e-labeling. Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines. H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act. H.R. 2884, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act. H.R. 2891 Preserve Access to Affordable Generics and Biosimilars Act H.R. 4521 America COMPETES Act of 2022 H.R. 2623 - Camerons Law; H.R. 5376 - Build Back Better Act; Issues related to the Orphan Drug Tax Credit; Issues related to the deduction of research and development expenditures Issues related to corporate and international tax reform Issues related to an appropriations hold on funding for a 2014 FDA rule that would provide electronic flexibilities related to package inserts (PI); Appropriations, FY 2022 and FY 2023; H.R. 2471, Consolidated Appropriations Act, 2022 H.R. 2471; Public Service Retirement Fairness Act of 2021 Issues related to intellectual property, data exclusivity, patent eligibility & patent law reform S. 1435, the Affordable Prescriptions for Patients Act
HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code BUD - Budget/Appropriations CPT - Copyright/Patent/Trademark
135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 21 - Office of Science & Technology Policy (OSTP) 1 - SENATE 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, P.O. BOX 15437, WILMINGTON, DE, 19850, US
THADDEUS FLOOD HELEN DWIGHT ELIZABETH BROOKS SUSIE AHN KATIE JONES CAROLINE QUAT AARON W HUNTER THADDEUS FLOOD HELEN DWIGHT SUSIE AHN ELIZABETH BROOKS CAROLINE QUAT KATIE JONES AARON W HUNTER HELEN DWIGHT SUSIE AHN ELIZABETH BROOKS AARON W HUNTER CAROLINE QUAT SUSIE AHN AARON W HUNTER HELEN DWIGHT ELIZABETH BROOKS KATIE JONES SUSIE AHN HELEN DWIGHT ELIZABETH BROOKS KATIE JONES HELEN DWIGHT ELIZABETH BROOKS SUSIE AHN KATIE JONES CAROLINE QUAT THADDEUS FLOOD AARON W HUNTER HELEN DWIGHT ELIZABETH BROOKS SUSIE AHN KATIE JONES CAROLINE QUAT THADDEUS FLOOD AARON W HUNTER